Anne De Groot, CEO of EpiVax, will testify before the Blue Ribbon Study Panel on Biodefense about encouraging innovative methods for solving existing and new biothreats. View a PDF of Annie’s testimony.
- Host Cell Proteins in COVID Vaccines? and …. Fearless Science World Tour!
- Meet the 6 newest EpiVax team members!
- AAPS NBC Tech Challenge Talk: Engineering Better Biologics: Does Nature Know Best?
- Hope is a vaccine / L’espoir, c’est un vaccin
- EpiVax Identifies T cell Epitopes critical to robust T cell immune response in SARS-CoV-2 , Results Published in NPJ Vaccines